JP2023519189A5 - - Google Patents
Info
- Publication number
- JP2023519189A5 JP2023519189A5 JP2022556000A JP2022556000A JP2023519189A5 JP 2023519189 A5 JP2023519189 A5 JP 2023519189A5 JP 2022556000 A JP2022556000 A JP 2022556000A JP 2022556000 A JP2022556000 A JP 2022556000A JP 2023519189 A5 JP2023519189 A5 JP 2023519189A5
- Authority
- JP
- Japan
- Prior art keywords
- extract
- weight
- ginsenosides
- composition
- total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2004121.6 | 2020-03-20 | ||
| GBGB2004121.6A GB202004121D0 (en) | 2020-03-20 | 2020-03-20 | Improved compositions |
| GB2005288.2 | 2020-04-09 | ||
| GBGB2005288.2A GB202005288D0 (en) | 2020-04-09 | 2020-04-09 | Improved compositions |
| PCT/EP2021/056788 WO2021185890A1 (en) | 2020-03-20 | 2021-03-17 | Ginsenoside compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519189A JP2023519189A (ja) | 2023-05-10 |
| JP2023519189A5 true JP2023519189A5 (https=) | 2024-03-27 |
| JP7850670B2 JP7850670B2 (ja) | 2026-04-23 |
Family
ID=75108332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556000A Active JP7850670B2 (ja) | 2020-03-20 | 2021-03-17 | ギンセノシド組成物 |
| JP2022555990A Active JP7808042B2 (ja) | 2020-03-20 | 2021-03-17 | ギンセノシド組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555990A Active JP7808042B2 (ja) | 2020-03-20 | 2021-03-17 | ギンセノシド組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230124503A1 (https=) |
| EP (2) | EP4121061A1 (https=) |
| JP (2) | JP7850670B2 (https=) |
| CN (2) | CN115315264A (https=) |
| AU (2) | AU2021238643A1 (https=) |
| BR (2) | BR112022016241A2 (https=) |
| CA (2) | CA3174698A1 (https=) |
| WO (2) | WO2021185897A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7850670B2 (ja) * | 2020-03-20 | 2026-04-23 | ジボダン エス エー | ギンセノシド組成物 |
| JP2023161983A (ja) * | 2022-04-26 | 2023-11-08 | 石川県公立大学法人 | サポニンを含む酪酸産生菌増殖能向上組成物、腸内常在菌増殖能向上組成物、乳酸菌増殖能向上組成物及びビフィズス菌増殖能向上組成物 |
| CN117224553B (zh) * | 2023-11-02 | 2025-08-12 | 浙江大学 | 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用 |
| CN117752706B (zh) * | 2023-12-20 | 2025-10-14 | 浙江天皇药业有限公司 | 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用 |
| WO2025261873A1 (en) | 2024-06-20 | 2025-12-26 | Givaudan Sa | Improvements in or relating to compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040202731A1 (en) * | 2003-04-08 | 2004-10-14 | Gow Robert T. | Rosmarinic acid composition |
| US20100278944A1 (en) | 2009-05-04 | 2010-11-04 | Naturex, S.A. | Application of american ginseng to enhance neurocognitive function |
| US9956241B2 (en) * | 2009-05-04 | 2018-05-01 | Naturex, S.A. | Application of American Ginseng to enhance neurocognitive function |
| US10456436B2 (en) * | 2013-11-04 | 2019-10-29 | Wen Luan Wendy Hsiao | Use of herbal saponins to regulate gut microflora |
| SG11202000258TA (en) | 2017-07-18 | 2020-02-27 | Senescence Life Sciences Pte Ltd | Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function |
| CN110613802A (zh) | 2018-06-20 | 2019-12-27 | 珠海岐微生物科技有限公司 | 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途 |
| CN109432304A (zh) * | 2018-12-03 | 2019-03-08 | 杭州胡庆余堂药业有限公司 | 一种含铁皮石斛组合物在药物制备中的应用 |
| JP7850670B2 (ja) | 2020-03-20 | 2026-04-23 | ジボダン エス エー | ギンセノシド組成物 |
-
2021
- 2021-03-17 JP JP2022556000A patent/JP7850670B2/ja active Active
- 2021-03-17 CA CA3174698A patent/CA3174698A1/en active Pending
- 2021-03-17 CN CN202180022225.5A patent/CN115315264A/zh active Pending
- 2021-03-17 AU AU2021238643A patent/AU2021238643A1/en active Pending
- 2021-03-17 AU AU2021238639A patent/AU2021238639A1/en active Pending
- 2021-03-17 EP EP21712999.8A patent/EP4121061A1/en active Pending
- 2021-03-17 CN CN202180022249.0A patent/CN115315266A/zh active Pending
- 2021-03-17 WO PCT/EP2021/056803 patent/WO2021185897A1/en not_active Ceased
- 2021-03-17 US US17/905,849 patent/US20230124503A1/en active Pending
- 2021-03-17 US US17/905,868 patent/US20230129389A1/en active Pending
- 2021-03-17 EP EP21713906.2A patent/EP4121076A1/en active Pending
- 2021-03-17 JP JP2022555990A patent/JP7808042B2/ja active Active
- 2021-03-17 WO PCT/EP2021/056788 patent/WO2021185890A1/en not_active Ceased
- 2021-03-17 CA CA3174699A patent/CA3174699A1/en active Pending
- 2021-03-17 BR BR112022016241A patent/BR112022016241A2/pt unknown
- 2021-03-17 BR BR112022015826A patent/BR112022015826A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023519189A5 (https=) | ||
| JP2020527583A5 (https=) | ||
| JP5979931B2 (ja) | 医薬組成物 | |
| JP2023518064A5 (https=) | ||
| JP2022521233A5 (https=) | ||
| US20220387455A1 (en) | Treatment of moderate to severe influenza | |
| HRP20211488T1 (hr) | Sastav i metoda za liječenje metaboličkih poremećaja | |
| WO2019114686A1 (en) | Composition for teeating dementia and preparation method and use thereof | |
| JP3114017B1 (ja) | 鎮痛健康補助食品 | |
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| JP2023537369A5 (https=) | ||
| JPWO2014010658A1 (ja) | ヒハツ配合製剤 | |
| WO2017101696A1 (zh) | 治疗急慢性呼吸困难的西药组合物及其制备方法 | |
| CN110882245A (zh) | 一种改善睡眠的组合物及其用途 | |
| CN117159679A (zh) | 一种治疗流感的中药组合物及其制备方法和应用 | |
| CN104286855A (zh) | 一种牛樟芝保健品及其用途 | |
| JP2024531799A5 (https=) | ||
| JP2024522163A5 (https=) | ||
| JPS6393722A (ja) | 医薬の処方 | |
| CN108066651B (zh) | 一种用于治疗抗抑郁药所致盗汗的健脾养阴中药组合物 | |
| CN112057559A (zh) | 霍山石斛提取物在预防、缓解和/或治疗尿酸性肾病药物中的应用 | |
| JP2006508993A5 (https=) | ||
| Mahler | Pro: Inhaled corticosteroids for chronic obstructive pulmonary disease | |
| CN102462758B (zh) | 一种用于降压的中药组合物及其足浴液制剂 | |
| Donohue et al. | The Effect of Baseline Rescue Medication Use on Lung Function and Patient-Reported Outcomes in Patients with COPD Treated with Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies |